Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire East Timor.
Press releases published on February 24, 2026
Feb. 24, 2026
Cannabix Technologies Closes Non-Brokered Private Placement
Indeterminate
GlobeNewswire
Feb. 24, 2026
Amwell® to Participate in Upcoming Investor Conference
Indeterminate
GlobeNewswire
Feb. 24, 2026
Cardiff Oncology Reports Full Year 2025 Results and Provides Business Update
Indeterminate
GlobeNewswire
Feb. 24, 2026
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
Indeterminate
GlobeNewswire
Feb. 24, 2026
Teva to Present at the Upcoming Investor Conferences in March
Indeterminate
GlobeNewswire
Feb. 24, 2026
Jasper Therapeutics to Present at 46th Annual TD Cowen Healthcare Conference
Indeterminate
GlobeNewswire
Feb. 24, 2026
Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Directors
Indeterminate
GlobeNewswire
Feb. 24, 2026
Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026
Indeterminate
GlobeNewswire
Feb. 24, 2026
Globus Medical Reports Fourth Quarter and Full Year 2025 Results
Indeterminate
GlobeNewswire
Feb. 24, 2026
Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results
Indeterminate
GlobeNewswire
Feb. 24, 2026
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives
Indeterminate
GlobeNewswire
Feb. 24, 2026
Aktis Oncology to Present at Upcoming March Investor Conferences
Indeterminate
GlobeNewswire
Feb. 24, 2026
UroGen Pharma to Present at the TD Cowen 46th Annual Health Care Conference
Indeterminate
GlobeNewswire
Feb. 24, 2026
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results
Indeterminate
GlobeNewswire
Feb. 24, 2026
Rapport Therapeutics to Participate in Upcoming Investor Conferences
Indeterminate
GlobeNewswire
Feb. 24, 2026
Vaxcyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Indeterminate
GlobeNewswire
Feb. 24, 2026
Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results
Indeterminate
GlobeNewswire
Feb. 24, 2026
Palvella Therapeutics Announces Proposed Public Offering
Indeterminate
GlobeNewswire
Feb. 24, 2026
Merit Medical Reports Fourth Quarter and Full Year 2025 Results and Issues Fiscal Year 2026 Guidance
Indeterminate
GlobeNewswire